amgen glp 1 agonist Triple Agonism Based Therapies for Obesity | Current Cardiovascular Risk Reports GLP-1 Analogues Transform Metabolic Disease

[DOI] [PubMed] [Google Scholar] 114.Andres-Ramos I, Blanco-Barrios S, Fernandez-Lopez E, Santos-Briz A

doi: 10.3389/fendo.2018.00649 Received 19 June 2018 Accepted 15 October 2018 Published 06 November 2018 Volume 9 - 2018 Edited by Marco Falasca, Curtin University, Australia Reviewed by Marta Letizia Hribal, Universit degli studi Magna Grcia di Catanzaro, Italy

Real-world persistence data will be particularly important to guide efforts for shoring up the chronic market opportunity, e.g., via digital health support programmes, such as the Omada Health-Evernorth partnership [8]

Int J Mol Sci (2019) 20(20):5064

[DOI] [PubMed] [Google Scholar] 58.Cooper ME